Monday, June 15, 2026

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Chinese TV Maker TCL Knocks Samsung From Top Spot

TCL surpasses Samsung to become the global TV shipment leader for the first time, capturing 16% market share in December.

Kim Ha Seong Joins Rays for Two Years, $29 Million After Free Agency Delay

Kim Ha Seong signs a two-year, $29 million contract with the Tampa Bay Rays, marking a significant investment for the team.

Tag: cancer drug

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us